Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor α protective?

McAlindon, 2000, Update on the epidemiology of systemic lupus erythematosus, Curr Opin Rheumatol, 12, 104, 10.1097/00002281-200003000-00004

Klinman, 1987, Systemic autoimmune disease arises from polyclonal B cell activation, J Exp Med, 165, 1755, 10.1084/jem.165.6.1755

Wallace, 2002

Williams, 1999, Anti-DNA and anti-nucleosome antibody affinity—a mirror image of lupus nephritis?, J Rheumatol, 26, 331

Funauchi, 1998, Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus, Scand J Rheumatol, 27, 219, 10.1080/030097498440859

Mosmann, 1989, TH1 and TH2 cells, Annu Rev Immunol, 7, 145, 10.1146/annurev.iy.07.040189.001045

Romagnani, 1997, The Th1/Th2 paradigm, Immunol Today, 18, 263, 10.1016/S0167-5699(97)80019-9

Viallard, 1999, Th1 [IL-2, interferon-gamma (IFN-gamma)] and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE), Clin Exp Immunol, 115, 189, 10.1046/j.1365-2249.1999.00766.x

Theofilopoulos, 2001, The role of IFN-gamma in systemic lupus erythematosus, Arthritis Res, 3, 136, 10.1186/ar290

Amerio, 2002, Increased IL-18 in patients with systemic lupus erythematosus: Relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines, Clin Exp Rheumatol, 20, 535

Liu, 1998, Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes, Cytokine, 10, 140, 10.1006/cyto.1997.0268

Liu, 1998, Impaired production of IL-12 in systemic lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE, Cytokine, 10, 148, 10.1006/cyto.1997.0269

Tokano, 1999, Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1- and Th2-derived cytokines, Clin Exp Immunol, 116, 169, 10.1046/j.1365-2249.1999.00862.x

Wong, 2000, Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus, Lupus, 9, 589, 10.1191/096120300678828703

Chang, 2002, The expression and significance of intracellular T helper cytokines in systemic lupus erythematosus, Immunol Invest, 31, 1, 10.1081/IMM-120003217

Robak, 2002, Proinflammatory interferon- gamma-inducing monokines (interleukine-12, interleukine-18, interleukine-15)—serum profile in patients with systemic lupus erythematosus, Eur Cytokine Netw, 13, 364

Jones, 1999, Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity, Autoimmunity, 31, 117, 10.3109/08916939908994055

Min, 2001, Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus, Scand J Rheumatol, 30, 159, 10.1080/030097401300162932

Liu, 1999, Impaired production of IL-12 in systemic lupus erythematosus. III: Deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL- 10 and IFN-gamma gene expression, Cytokine, 11, 805, 10.1006/cyto.1999.0512

Lauwerys, 2002, Serum IL-12 in systemic lupus erythematosus, Lupus, 11, 384, 10.1191/0961203302lu213oa

Ronnelid, 2003, Immune complexes from SLE sera induce IL10 production from normal peripherical blood mononuclear cells by an FcgammaRII dependent mechanism, Ann Rheum Dis, 62, 37, 10.1136/ard.62.1.37

Miret, 2001, Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alpha-TNF) with the activity of systemic lupus erythematosus, Anticancer Res, 21, 3053

Tan, 1982, The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, 1271, 10.1002/art.1780251101

Gladman, 1997, The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus, Arthritis Rheum, 40, 809, 10.1002/art.1780400506

Grossman, 2002, Definition, classification, activity, and damage indices, 19

1999

2001

Oppenheim, 1994, Cytokines, 105

Aggarwal, 1985, Human tumor necrosis factor. Production, purification, and characterization, J Biol Chem, 260, 2345, 10.1016/S0021-9258(18)89560-6

Jacob, 1992, Tumor necrosis factor α in autoimmunity, Immunol Today, 13, 122, 10.1016/0167-5699(92)90107-I

Mageed, 2002, Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production, Lupus, 11, 850, 10.1191/0961203302lu306rr

Charles, 2000, Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with Infliximab, a monoclonal antibody to tumor necrosis factor alpha, Arthritis Rheum, 43, 2383, 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D

Debant, 2003, Anti-TNF-α-induced systemic lupus syndrome, Clin Rheumatol, 22, 56, 10.1007/s10067-002-0654-5

Ballou, 1982, Clinical features of systemic lupus erythematosus, Arthritis Rheum, 25, 55, 10.1002/art.1780250109

Aringer, 2003, Complex cytokine effects in a complex autoimmune disease, Arthritis Res Ther, 5, 172, 10.1186/ar770

Abdi, 2002, IL-12, Scand J Immunol, 56, 1, 10.1046/j.1365-3083.2002.01101.x

Bertagnolli, 1992, IL-12 augments antigen-dependent proliferation of activated T lymphocytes, J Immunol, 149, 3778, 10.4049/jimmunol.149.12.3778

Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annu Rev Immunol, 19, 683, 10.1146/annurev.immunol.19.1.683

Verthelyi, 2001, Disassociation of sex hormone levels and cytokine production in SLE patients, Lupus, 10, 352, 10.1191/096120301674365881

Farrar, 1993, The molecular cell biology of interferon-gamma and its receptor, Annu Rev Immunol, 11, 571, 10.1146/annurev.iy.11.040193.003035

Elenkov, 2002, Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity, Ann N Y Acad Sci, 966, 290, 10.1111/j.1749-6632.2002.tb04229.x

Price, 1999, The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases, Immunol Rev, 167, 257, 10.1111/j.1600-065X.1999.tb01398.x

Lio, 2001, A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects, Hum Immunol, 62, 705, 10.1016/S0198-8859(01)00264-6

Wu, 2003, Polymorphisms of the interleukin-4 gene in chinese patients with systemic lupus erythematosus in Taiwan, Lupus, 12, 21, 10.1191/0961203303lu249oa

Miyake, 2002, Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis, Rheumatol, 41, 518, 10.1093/rheumatology/41.5.518

Van der Linden, 2001, Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus, Genes Immun, 2, 373, 10.1038/sj.gene.6363794

Eskdale, 1997, Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus, Tissue Antigens, 49, 635, 10.1111/j.1399-0039.1997.tb02812.x